Plus Therapeutics, Inc.
General ticker "PSTV" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $15.7M (TTM average)
Plus Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -12.1%.
Estimated limits based on current volatility of 4.0%: low 0.59$, high 0.64$
Factors to consider:
- Total employees count: 20 (+17.6%) as of 2023
- Top business risk factors: Insufficient funding, Market competition, Regulatory and compliance, Labor/talent shortage/retention, Cybersecurity threats
- Current price 22.0% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.84$, 2.64$]
- 2025-12-31 to 2026-12-31 estimated range: [0.80$, 2.50$]
Financial Metrics affecting the PSTV estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -146.42 <= 0.33
- Negative: Shareholder equity ratio, % of -134.92 <= 18.93
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term PSTV quotes
Long-term PSTV plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.22MM | $4.91MM | $5.82MM |
| Operating Expenses | $19.94MM | $18.23MM | $20.52MM |
| Operating Income | $-19.71MM | $-13.32MM | $-14.70MM |
| Non-Operating Income | $-0.56MM | $0.01MM | $1.72MM |
| Interest Expense | $0.71MM | $0.40MM | $3.72MM |
| R&D Expense | $9.70MM | $9.69MM | $10.58MM |
| Income(Loss) | $-20.27MM | $-13.32MM | $-12.98MM |
| Profit(Loss)* | $-20.27MM | $-13.32MM | $-12.98MM |
| Stockholders Equity | $6.45MM | $-1.35MM | $-8.95MM |
| Assets | $23.87MM | $11.39MM | $6.63MM |
| Operating Cash Flow | $-12.97MM | $-12.85MM | $-10.55MM |
| Capital expenditure | $0.76MM | $0.16MM | $0.15MM |
| Investing Cash Flow | $-0.76MM | $-0.16MM | $-4.11MM |
| Financing Cash Flow | $13.45MM | $3.44MM | $6.19MM |
| Earnings Per Share** | $-11.58 | $-4.24 | $-1.95 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.